Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Manes, G; Mosca, S; de Nucci, C; Lombardi, G; Lioniello, M; Balzano, A
   High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection
   DIGESTIVE AND LIVER DISEASE
   
   G. Manes et al., "High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection", DIG LIVER D, 33(8), 2001, pp. 665-670
2. Gisbert, JP; Cruzado, AI; Benito, LM; Carpio, D; Perez-Poveda, JJ; Gonzalez, L; de Pedro, A; Valbuena, M; Prieto, B; Cabrera, MM; Cantero, J; Pajares, JM
   Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?
   DIGESTIVE AND LIVER DISEASE
   
   J.P. Gisbert et al., "Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?", DIG LIVER D, 33(7), 2001, pp. 539-545
3. Ponzetto, A; Fagoonee, S; Pellicano, R
   Helicobacter pylori and liver: an actor with three roles?
   DIGESTIVE AND LIVER DISEASE
   
   A. Ponzetto et al., "Helicobacter pylori and liver: an actor with three roles?", DIG LIVER D, 33(5), 2001, pp. 399-401
4. Marrollo, M; Latella, G; Melideo, D; Storelli, E; Iannarelli, R; Stornelli, P; Valenti, M; Caprilli, R
   Increased prevalence of Helicobacter pylori in patients with diabetes mellitus
   DIGESTIVE AND LIVER DISEASE
   
   M. Marrollo et al., "Increased prevalence of Helicobacter pylori in patients with diabetes mellitus", DIG LIVER D, 33(1), 2001, pp. 21-29
5. Avidan, B; Melzer, E; Keller, N; Bar-Meir, S
   The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication
   ISRAEL MEDICAL ASSOCIATION JOURNAL
   
   B. Avidan et al., "The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication", ISR MED ASS, 3(3), 2001, pp. 163-165
6. Aalykke, C; Lauritsen, K
   Epidemiology of NSAID-related gastroduodenal mucosal injury
   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
   
   C. Aalykke e K. Lauritsen, "Epidemiology of NSAID-related gastroduodenal mucosal injury", BEST PR RES, 15(5), 2001, pp. 705-722
7. Bidaut-Russell, M; Gabriel, SE
   Adverse gastrointestinal effects of NSAIDs: consequences and costs
   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
   
   M. Bidaut-Russell e S.E. Gabriel, "Adverse gastrointestinal effects of NSAIDs: consequences and costs", BEST PR RES, 15(5), 2001, pp. 739-753
8. McCarthy, DM
   Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs
   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
   
   D.M. McCarthy, "Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs", BEST PR RES, 15(5), 2001, pp. 755-773
9. Bazzoli, F; De Luca, L; Graham, DY
   Helicobacter pylori infection and the use of NSAIDs
   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
   
   F. Bazzoli et al., "Helicobacter pylori infection and the use of NSAIDs", BEST PR RES, 15(5), 2001, pp. 775-785
10. Howden, CW; Leontiadis, GI
    Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    C.W. Howden e G.I. Leontiadis, "Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease", BEST PR RES, 15(3), 2001, pp. 401-412
11. Chan, FKL; Sung, JJY
    Role of acid suppressants in prophylaxis of NSAID damage
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    F.K.L. Chan e J.J.Y. Sung, "Role of acid suppressants in prophylaxis of NSAID damage", BEST PR RES, 15(3), 2001, pp. 433-445
12. van Leerdam, ME; Rauws, EAJ
    The role of acid suppressants in upper gastrointestinal ulcer bleeding
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    M.E. van Leerdam e E.A.J. Rauws, "The role of acid suppressants in upper gastrointestinal ulcer bleeding", BEST PR RES, 15(3), 2001, pp. 463-475
13. Simoens, M; Rutgeerts, P
    Non-variceal upper gastrointestinal bleeding
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    M. Simoens e P. Rutgeerts, "Non-variceal upper gastrointestinal bleeding", BEST PR RES, 15(1), 2001, pp. 121-133
14. Rodriguez, LAG; Hernandez-Diaz, S
    The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents
    ARTHRITIS RESEARCH
    
    L.A.G. Rodriguez e S. Hernandez-Diaz, "The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents", ARTHRITIS R, 3(2), 2001, pp. 98-101
15. Dundon, WG; de Bernard, M; Montecucco, C
    Virulence factors of Helicobacter pylori
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    
    W.G. Dundon et al., "Virulence factors of Helicobacter pylori", INT J MED M, 290(8), 2001, pp. 647-658
16. Arlt, GD; Leyh, M
    Incidence and pathophysiology of peptic ulcer bleeding
    LANGENBECKS ARCHIVES OF SURGERY
    
    G.D. Arlt e M. Leyh, "Incidence and pathophysiology of peptic ulcer bleeding", LANG ARCH S, 386(2), 2001, pp. 75-81
17. Seewald, S; Seitz, U; Thonke, F; Sriram, PVJ; He, XK; Soehendra, N
    Interventional endoscopic treatment of upper gastrointestinal bleeding - when, how, and how often
    LANGENBECKS ARCHIVES OF SURGERY
    
    S. Seewald et al., "Interventional endoscopic treatment of upper gastrointestinal bleeding - when, how, and how often", LANG ARCH S, 386(2), 2001, pp. 88-97
18. Schoenberg, MH
    Surgical therapy for peptic ulcer and nonvariceal bleeding
    LANGENBECKS ARCHIVES OF SURGERY
    
    M.H. Schoenberg, "Surgical therapy for peptic ulcer and nonvariceal bleeding", LANG ARCH S, 386(2), 2001, pp. 98-103
19. Metzger, J; Styger, S; Sieber, C; von Fliie, M; Vogelbach, P; Harder, F
    Prevalence of Helicobacter pylori infection in peptic ulcer perforations
    SWISS MEDICAL WEEKLY
    
    J. Metzger et al., "Prevalence of Helicobacter pylori infection in peptic ulcer perforations", SWISS MED W, 131(7-8), 2001, pp. 99-103
20. Odeh, M; Oliven, A
    Hepatotoxicity related to sucralfate
    HEPATOLOGY RESEARCH
    
    M. Odeh e A. Oliven, "Hepatotoxicity related to sucralfate", HEPATOL RES, 20(2), 2001, pp. 255-258
21. Williamson, JS
    Helicobacter pylori: Current chemotherapy and new targets for drug design
    CURRENT PHARMACEUTICAL DESIGN
    
    J.S. Williamson, "Helicobacter pylori: Current chemotherapy and new targets for drug design", CUR PHARM D, 7(5), 2001, pp. 355-392
22. Trend, MA; Jorgensen, MA; Hazell, SL; Mendz, GL
    Oxidases and reductases are involved in metronidazole sensitivity in Helicobacter pylori
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    
    M.A. Trend et al., "Oxidases and reductases are involved in metronidazole sensitivity in Helicobacter pylori", INT J BIO C, 33(2), 2001, pp. 143-153
23. de Boer, WA
    A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    W.A. de Boer, "A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule", EXPERT OP I, 10(8), 2001, pp. 1559-1566
24. Gomollon, F; Sicilia, B
    Helicobacter pylori: strategies for treatment
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    F. Gomollon e B. Sicilia, "Helicobacter pylori: strategies for treatment", EXPERT OP I, 10(7), 2001, pp. 1231-1241
25. Schabowski, J
    Is there a territorial differentiation in the prevalence of peptic ulcer among rural population in Poland?
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
    
    J. Schabowski, "Is there a territorial differentiation in the prevalence of peptic ulcer among rural population in Poland?", ANN AG EN M, 8(1), 2001, pp. 57-62
26. Rentz, AM; Battista, C; Trudeau, E; Jones, R; Robinson, P; Sloan, S; Mathur, S; Frank, L; Revicki, DA
    Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies - A review and synthesis of the literature
    PHARMACOECONOMICS
    
    A.M. Rentz et al., "Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies - A review and synthesis of the literature", PHARMACOECO, 19(4), 2001, pp. 349-363
27. Burke, TA; Zabinski, RA; Pettitt, D; Maniadakis, N; Maurath, CJ; Goldstein, JL
    A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis
    PHARMACOECONOMICS
    
    T.A. Burke et al., "A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis", PHARMACOECO, 19(1), 2001, pp. 33-47
28. Perez, TV; Gisbert, JR; Garcia, JMP
    Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infection
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    T.V. Perez et al., "Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infection", REV ESP E D, 93(7), 2001, pp. 476-480
29. Mones, J; Rodrigo, L; Sancho, F; Martin, L; Boixeda, D; Artes, MT; Garcia-Cases, C
    Helicobacter pylori eradication versus one-year maintenance therapy: effect on relapse and gastritis outcome
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    J. Mones et al., "Helicobacter pylori eradication versus one-year maintenance therapy: effect on relapse and gastritis outcome", REV ESP E D, 93(6), 2001, pp. 381-389
30. Baffone, W; Pianetti, A; Citterio, B; Lombardelli, G; Vittoria, E; Bruscolini, F
    Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin
    JOURNAL OF CHEMOTHERAPY
    
    W. Baffone et al., "Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin", J CHEMOTHER, 13(2), 2001, pp. 126-132
31. Falk, P
    Helicobacter pylori colonisation of the human stomach - Persistence at a price
    EUROPEAN JOURNAL OF SURGERY
    
    P. Falk, "Helicobacter pylori colonisation of the human stomach - Persistence at a price", EURO J SURG, 167, 2001, pp. 12-23
32. Clarke, KO; Harrison, LE
    Surgical implications of Helicobacter pylori infection
    FRONTIERS IN BIOSCIENCE
    
    K.O. Clarke e L.E. Harrison, "Surgical implications of Helicobacter pylori infection", FRONT BIOSC, 6, 2001, pp. E119-E128
33. Lake, JM; Chey, WD
    Testing for Helicobacter pylori in the clinical setting
    FRONTIERS IN BIOSCIENCE
    
    J.M. Lake e W.D. Chey, "Testing for Helicobacter pylori in the clinical setting", FRONT BIOSC, 6, 2001, pp. E129-E136
34. Schwesinger, WH; Page, CP; Sirinek, KR; Gaskill, HV; Melnick, G; Strodel, WE
    Operations for peptic ulcer disease: Paradigm lost
    JOURNAL OF GASTROINTESTINAL SURGERY
    
    W.H. Schwesinger et al., "Operations for peptic ulcer disease: Paradigm lost", J GASTRO S, 5(4), 2001, pp. 438-443
35. Evans, DJ; Evans, DG
    Helicobacter pylori CagA: Analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor
    HELICOBACTER
    
    D.J. Evans e D.G. Evans, "Helicobacter pylori CagA: Analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor", HELICOBACT, 6(3), 2001, pp. 187-198
36. Pineros, DMC; Riveros, SCH; Marin, JDM; Ricardo, O; Diaz, OO
    Helicobacter pylori in gastric cancer and peptic ulcer disease in a Colombian population. Strain heterogeneity and antibody profiles
    HELICOBACTER
    
    D.M.C. Pineros et al., "Helicobacter pylori in gastric cancer and peptic ulcer disease in a Colombian population. Strain heterogeneity and antibody profiles", HELICOBACT, 6(3), 2001, pp. 199-206
37. Bodger, K; Wyatt, JI; Heatley, RV
    Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy
    HELICOBACTER
    
    K. Bodger et al., "Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy", HELICOBACT, 6(3), 2001, pp. 216-224
38. Elitsur, Y; Lawrence, Z
    Non-Helicobacter pylori related duodenal ulcer disease in children
    HELICOBACTER
    
    Y. Elitsur e Z. Lawrence, "Non-Helicobacter pylori related duodenal ulcer disease in children", HELICOBACT, 6(3), 2001, pp. 239-243
39. Meyer, JM; Silliman, NP; Dixon, CA; Siepman, NY; Sugg, JE; Hopkins, RJ
    Helicobacter pylori and early duodenal ulcer status post-treatment: a review
    HELICOBACTER
    
    J.M. Meyer et al., "Helicobacter pylori and early duodenal ulcer status post-treatment: a review", HELICOBACT, 6(2), 2001, pp. 84-92
40. Paoluzi, OA; Rossi, P; Montesano, C; Bernardi, S; Carnieri, E; Marchione, OP; Nardi, F; Iacopini, F; Pica, R; Paoluzi, P
    Discrepancy between polymerase chain reaction assay and Western blot analysis in the assessment of CagA status in dyspeptic patients
    HELICOBACTER
    
    O.A. Paoluzi et al., "Discrepancy between polymerase chain reaction assay and Western blot analysis in the assessment of CagA status in dyspeptic patients", HELICOBACT, 6(2), 2001, pp. 130-135
41. Yamamoto, S; Kaneko, H; Konagaya, T; Mori, S; Kotera, H; Hayakawa, T; Yamaguchi, C; Uruma, M; Kusugami, K; Mitsuma, T
    Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients
    HELICOBACTER
    
    S. Yamamoto et al., "Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients", HELICOBACT, 6(2), 2001, pp. 136-145
42. Gisbert, JP; Marcos, S; Gisbert, JL; Pajares, JM
    High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication
    HELICOBACTER
    
    J.P. Gisbert et al., "High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication", HELICOBACT, 6(2), 2001, pp. 157-162
43. Demirturk, L; Ozel, AM; Yazgan, Y; Solmazgul, E; Yildirim, S; Gultepe, M; Gurbuz, AK
    CagA status in dyspeptic patients with and without peptic ulcer disease inTurkey: Association with histopathologic findings
    HELICOBACTER
    
    L. Demirturk et al., "CagA status in dyspeptic patients with and without peptic ulcer disease inTurkey: Association with histopathologic findings", HELICOBACT, 6(2), 2001, pp. 163-168
44. May, N; Epstein, J; Osborne, B
    Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    
    N. May et al., "Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry", ORAL SURG O, 92(4), 2001, pp. 399-405
45. Taneike, I; Tamura, Y; Shimizu, T; Yamashiro, Y; Yamamoto, T
    Helicobacter pylori intrafamilial infections: Change in source of infection of a child from father to mother after eradication therapy
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    I. Taneike et al., "Helicobacter pylori intrafamilial infections: Change in source of infection of a child from father to mother after eradication therapy", CL DIAG LAB, 8(4), 2001, pp. 731-739
46. Erstad, BL
    Proton-pump inhibitors for acute peptic ulcer bleeding
    ANNALS OF PHARMACOTHERAPY
    
    B.L. Erstad, "Proton-pump inhibitors for acute peptic ulcer bleeding", ANN PHARMAC, 35(6), 2001, pp. 730-740
47. Langman, MJS
    Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    
    M.J.S. Langman, "Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?", PHARMA D S, 10(1), 2001, pp. 13-19
48. Schenker, MP; Duszak, R; Soulen, MC; Smith, KP; Baum, RA; Cope, C; Freiman, DB; Roberts, DA; Shlansky-Goldberg, RD
    Upper gastrointestinal hemorrhage and transcatheter embolotherapy: Clinical and technical factors impacting success and survival
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    
    M.P. Schenker et al., "Upper gastrointestinal hemorrhage and transcatheter embolotherapy: Clinical and technical factors impacting success and survival", J VAS INT R, 12(11), 2001, pp. 1263-1271
49. Rodriguez, LAG; Hernandez-Diaz, S
    Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs
    EPIDEMIOLOGY
    
    L.A.G. Rodriguez e S. Hernandez-Diaz, "Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs", EPIDEMIOLOG, 12(5), 2001, pp. 570-576
50. Goodman, KJ; Cockburn, M
    The role of epidemiology in understanding the health effects of Helicobacter pylori
    EPIDEMIOLOGY
    
    K.J. Goodman e M. Cockburn, "The role of epidemiology in understanding the health effects of Helicobacter pylori", EPIDEMIOLOG, 12(2), 2001, pp. 266-271
51. Baba, M; Konno, H; Tanaka, T; Kamiya, K; Baba, S; Sugimura, H; Nakamura, S
    Relationship of p53 and Helicobacter pylori to clinicopathological features of human remnant stomach cancer after gastric surgery for primary gastriccancer
    ONCOLOGY REPORTS
    
    M. Baba et al., "Relationship of p53 and Helicobacter pylori to clinicopathological features of human remnant stomach cancer after gastric surgery for primary gastriccancer", ONCOL REP, 8(4), 2001, pp. 831-834
52. Kim, SY; Woo, CW; Lee, YM; Son, BR; Kim, JW; Chae, HB; Youn, SJ; Park, SM
    Genotyping CagA, VacA subtype, IceA1, and BabA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases
    JOURNAL OF KOREAN MEDICAL SCIENCE
    
    S.Y. Kim et al., "Genotyping CagA, VacA subtype, IceA1, and BabA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases", J KOR MED S, 16(5), 2001, pp. 579-584
53. Ma, ZF; Wang, ZY; Zhang, JR; Gong, P; Chen, HL
    Carcinogenic potential of duodenal reflux juice from patients with long-standing postgastrectomy
    WORLD JOURNAL OF GASTROENTEROLOGY
    
    Z.F. Ma et al., "Carcinogenic potential of duodenal reflux juice from patients with long-standing postgastrectomy", WORLD J GAS, 7(3), 2001, pp. 376-380
54. Suda, Y; Kim, YM; Ogawa, T; Yasui, N; Hasegawa, Y; Kashihara, W; Shimoyama, T; Aoyama, K; Nagata, K; Tamura, T; Kusumoto, S
    Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206
    JOURNAL OF ENDOTOXIN RESEARCH
    
    Y. Suda et al., "Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206", J ENDOTOX R, 7(2), 2001, pp. 95-104
55. Furuta, T; Shirai, N; Takashima, M; Xiao, F; Hanai, H; Nakagawa, K; Sugimura, H; Ohashi, K; Ishizaki, T
    Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin
    PHARMACOGENETICS
    
    T. Furuta et al., "Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin", PHARMACOGEN, 11(4), 2001, pp. 341-348
56. Avidan, B; Sonnenberg, A; Schnell, TG; Budiman-Mak, E; Sontag, SJ
    Risk factors of oesophagitis in arthritic patients
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    B. Avidan et al., "Risk factors of oesophagitis in arthritic patients", EUR J GASTR, 13(9), 2001, pp. 1095-1099
57. Hsu, CC; Chen, JJ; Hu, TH; Lu, SN; Changchien, CS
    Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    C.C. Hsu et al., "Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection", EUR J GASTR, 13(8), 2001, pp. 921-926
58. Ell, C; Schoerner, C; Solbach, W; Stolte, M; Vieth, M; Ridl, W; Moser, W
    The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    C. Ell et al., "The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori", EUR J GASTR, 13(6), 2001, pp. 685-691
59. Gerson, LB; Triadafilopoulos, G
    Proton pump inhibitors and their drug interactions: an evidence-based approach
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    L.B. Gerson e G. Triadafilopoulos, "Proton pump inhibitors and their drug interactions: an evidence-based approach", EUR J GASTR, 13(5), 2001, pp. 611-616
60. Goh, KL; Parasakthi, N
    The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    K.L. Goh e N. Parasakthi, "The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country", EUR J GASTR, 13(2), 2001, pp. 177-183
61. de Boer, WA; Tytgat, GNJ
    Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    W.A. de Boer e G.N.J. Tytgat, "Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?", EUR J GASTR, 13(11), 2001, pp. 1281-1284
62. Church, NI; Palmer, KR
    Relevance of the Rockall score in patients undergoing endoscopic therapy for peptic ulcer haemorrhage
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    N.I. Church e K.R. Palmer, "Relevance of the Rockall score in patients undergoing endoscopic therapy for peptic ulcer haemorrhage", EUR J GASTR, 13(10), 2001, pp. 1149-1152
63. van der Wouden, EJ; Thijs, JC; van Zwet, AA; Kleibeuker, JH
    Six-year follow-up after successful triple therapy for Helicobacter pyloriinfection in patients with peptic ulcer disease
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    E.J. van der Wouden et al., "Six-year follow-up after successful triple therapy for Helicobacter pyloriinfection in patients with peptic ulcer disease", EUR J GASTR, 13(10), 2001, pp. 1235-1239
64. Ohara, T; Arakawa, T; Higuchi, K; Kaneda, K
    Overexpression of co-stimulatory molecules in peripheral mononuclear cellsof Helicobacter pylori-positive peptic ulcer patients: possible differencein host responsiveness compared with non-ulcer patients
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    T. Ohara et al., "Overexpression of co-stimulatory molecules in peripheral mononuclear cellsof Helicobacter pylori-positive peptic ulcer patients: possible differencein host responsiveness compared with non-ulcer patients", EUR J GASTR, 13(1), 2001, pp. 11-18
65. Cicero, AFG; Gaddi, A
    Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions
    PHYTOTHERAPY RESEARCH
    
    A.F.G. Cicero e A. Gaddi, "Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions", PHYTOTHER R, 15(4), 2001, pp. 277-289
66. Celis, H; Thijs, L; Staessen, JA; Birkenhager, WH; Bulpitt, CJ; de Leeuw, PW; Leonetti, G; Nachev, C; Tuomilehto, J; Fagard, RH
    Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial
    JOURNAL OF HUMAN HYPERTENSION
    
    H. Celis et al., "Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial", J HUM HYPER, 15(9), 2001, pp. 613-618
67. Ding, HJ; Liu, YC; Peng, CF; Wang, WM; Chen, YW; Huang, YF; Lin, CC; Chen, CY
    An efficient method for the culture of Helicobacter pylori from gastric biopsies with two-section petri dishes
    JOURNAL OF GASTROENTEROLOGY
    
    H.J. Ding et al., "An efficient method for the culture of Helicobacter pylori from gastric biopsies with two-section petri dishes", J GASTRO, 36(4), 2001, pp. 237-241
68. Kim, HS; Lee, DK; Kim, KH; Jeong, YS; Kim, JW; Seo, JI; Baik, SK; Kwon, SO; Cho, MY
    Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positivepeptic ulcer
    JOURNAL OF GASTROENTEROLOGY
    
    H.S. Kim et al., "Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positivepeptic ulcer", J GASTRO, 36(2), 2001, pp. 96-102
69. Leong, RWL; Chan, FKL; Sung, JJY
    Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate?
    JOURNAL OF GASTROENTEROLOGY
    
    R.W.L. Leong et al., "Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate?", J GASTRO, 36(11), 2001, pp. 731-739
70. Sarkio, S; Rautelin, H; Kyllonen, L; Honkanen, E; Salmela, K; Halme, L
    Should Helicobacter pylori infection be treated before kidney transplantation?
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    S. Sarkio et al., "Should Helicobacter pylori infection be treated before kidney transplantation?", NEPH DIAL T, 16(10), 2001, pp. 2053-2057
71. Feng, CY; Hsu, WM; Chen, Y
    Perforated peptic ulcer in an infant
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    
    C.Y. Feng et al., "Perforated peptic ulcer in an infant", J FORMOS ME, 100(2), 2001, pp. 131-133
72. Owen, RJ; Peters, TM; Varea, R; Teare, EL; Saverymuttu, S
    Molecular epidemiology of Helicobacter pylori in England: prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    
    R.J. Owen et al., "Molecular epidemiology of Helicobacter pylori in England: prevalence of cag pathogenicity island markers and IS605 presence in relation to patient age and severity of gastric disease", FEMS IM MED, 30(1), 2001, pp. 65-71
73. Vincze, AK; Karadi, O; Hunyady, B; Pakodi, F; Suto, G; Mozsik, G
    One year follow-up of patients after successful helicobacter pylori eradication therapy
    JOURNAL OF PHYSIOLOGY-PARIS
    
    A.K. Vincze et al., "One year follow-up of patients after successful helicobacter pylori eradication therapy", J PHYSL-PAR, 95(1-6), 2001, pp. 457-460
74. Pechere, JC
    New perspectives on macrolide antibiotics
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    J.C. Pechere, "New perspectives on macrolide antibiotics", INT J ANT A, 18, 2001, pp. S93-S97
75. He, JX; Akao, T; Nishino, T; Tani, T
    The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-Tang
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    J.X. He et al., "The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-Tang", BIOL PHAR B, 24(12), 2001, pp. 1395-1399
76. Helderman, JH
    Prophylaxis and treatment of gastrointestinal complications following transplantation
    CLINICAL TRANSPLANTATION
    
    J.H. Helderman, "Prophylaxis and treatment of gastrointestinal complications following transplantation", CLIN TRANSP, 15, 2001, pp. 29-35
77. Bontems, P; Devaster, JM; Corvaglia, L; Dezsofi, A; van den Borre, C; Goutier, S; Butzler, JP; Cadranel, S
    Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    P. Bontems et al., "Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children", PEDIAT INF, 20(11), 2001, pp. 1033-1038
78. Mikuls, TR; Saag, KG
    Comorbidity in rheumatoid arthritis
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    
    T.R. Mikuls e K.G. Saag, "Comorbidity in rheumatoid arthritis", RHEUM DIS C, 27(2), 2001, pp. 283-303
79. Straus, WL; Ofman, JJ
    Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs - Epidemiologic and economic issues
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    
    W.L. Straus e J.J. Ofman, "Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs - Epidemiologic and economic issues", GASTRO CLIN, 30(4), 2001, pp. 895
80. Hawkey, CJ
    Gastrointestinal safety of COX-2 specific inhibitors
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    
    C.J. Hawkey, "Gastrointestinal safety of COX-2 specific inhibitors", GASTRO CLIN, 30(4), 2001, pp. 921
81. Chan, FKL
    Helicobacter pylori and nonsteroidal anti-inflammatory drugs
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    
    F.K.L. Chan, "Helicobacter pylori and nonsteroidal anti-inflammatory drugs", GASTRO CLIN, 30(4), 2001, pp. 937
82. Farrell, AJ; Friedman, LS
    Gastrointestinal bleeding in the elderly
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    
    A.J. Farrell e L.S. Friedman, "Gastrointestinal bleeding in the elderly", GASTRO CLIN, 30(2), 2001, pp. 377
83. Winbery, SL; Blaho, KE
    Dyspepsia in pregnancy
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    
    S.L. Winbery e K.E. Blaho, "Dyspepsia in pregnancy", OB GYN CLIN, 28(2), 2001, pp. 333
84. Wassef, W; Obando, J; Sharma, A
    Upper gastrointestinal bleeding of nonvariceal origin in the ICU setting
    JOURNAL OF INTENSIVE CARE MEDICINE
    
    W. Wassef et al., "Upper gastrointestinal bleeding of nonvariceal origin in the ICU setting", J INTENS C, 16(3), 2001, pp. 105-113
85. Chaun, H
    Update on the role of H pylori infection in gastrointestinal disorders
    CANADIAN JOURNAL OF GASTROENTEROLOGY
    
    H. Chaun, "Update on the role of H pylori infection in gastrointestinal disorders", CAN J GASTR, 15(4), 2001, pp. 251-255
86. Jacobson, K; Chiba, N; Chen, Y; Barrientos, M; James, C; Riddell, RH; Hunt, RH
    Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease
    CANADIAN JOURNAL OF GASTROENTEROLOGY
    
    K. Jacobson et al., "Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease", CAN J GASTR, 15(1), 2001, pp. 29-39
87. Koide, N; Hiraguri, M; Nishio, A; Hanazaki, K; Adachi, W; Shikama, N; Oguchi, M; Maezawa, T; Amano, J
    Ulcer in the gastric tube for esophageal replacement: A comparison of 12 esophageal cancer patients with or without postoperative radiotherapy
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    N. Koide et al., "Ulcer in the gastric tube for esophageal replacement: A comparison of 12 esophageal cancer patients with or without postoperative radiotherapy", J GASTR HEP, 16(2), 2001, pp. 137-141
88. Zevering, Y
    Vaccine against Helicobacter pylori?
    ANNALS OF MEDICINE
    
    Y. Zevering, "Vaccine against Helicobacter pylori?", ANN MED, 33(3), 2001, pp. 156-166
89. de Korwin, JD
    Eradication of Helicobacter pylori - Required in patients with gastroesophageal reflux?
    PRESSE MEDICALE
    
    J.D. de Korwin, "Eradication of Helicobacter pylori - Required in patients with gastroesophageal reflux?", PRESSE MED, 30(26), 2001, pp. 1313-1320
90. Beyth, RJ
    Hemorrhagic complications of oral anticoagulant therapy
    CLINICS IN GERIATRIC MEDICINE
    
    R.J. Beyth, "Hemorrhagic complications of oral anticoagulant therapy", CLIN GERIAT, 17(1), 2001, pp. 49
91. Yeh, JL; Peng, YC; Tung, CF; Chen, GH; Chow, WK; Chang, CS; Yeh, HZ; Poon, SK
    Role of Helicobacter pylori in cirrhotic patients with dyspepsia: A C-13-urea breath test study
    ADVANCES IN THERAPY
    
    J.L. Yeh et al., "Role of Helicobacter pylori in cirrhotic patients with dyspepsia: A C-13-urea breath test study", ADV THER, 18(3), 2001, pp. 140-150
92. Sakai, T; Aoyama, N; Kita, T; Sakaeda, T; Nishiguchi, K; Nishitora, Y; Hohda, T; Sirasaka, D; Tamura, T; Tanigawara, Y; Kasuga, M; Okumura, K
    CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects
    PHARMACEUTICAL RESEARCH
    
    T. Sakai et al., "CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects", PHARM RES, 18(6), 2001, pp. 721-727
93. Kita, T; Tanigawara, Y; Aoyama, N; Hohda, T; Saijoh, Y; Komada, F; Sakaeda, T; Okumura, K; Sakai, T; Kasuga, M
    CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability
    PHARMACEUTICAL RESEARCH
    
    T. Kita et al., "CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability", PHARM RES, 18(5), 2001, pp. 615-621
94. Capet, C; Czernichow, P; Dupas, JL; Goria, O; Gouerou, H; Hochain, P; Amouretti, M; Hermann, H; Colin, R
    Upper gastrointestinal bleeding in patients treated by low-dose aspirin
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    C. Capet et al., "Upper gastrointestinal bleeding in patients treated by low-dose aspirin", GASTRO CL B, 25(3), 2001, pp. 233-238
95. Bani-Hani, KE; Hammouri, SM
    Prevalence of Helicobacter pylori in Northern Jordan - Endoscopy based study
    SAUDI MEDICAL JOURNAL
    
    K.E. Bani-Hani e S.M. Hammouri, "Prevalence of Helicobacter pylori in Northern Jordan - Endoscopy based study", SAUDI MED J, 22(10), 2001, pp. 843-847
96. Rosandic, M
    Antibiotic-resistance patterns of Helicobacter pylori in Croatia: Cohort study
    CROATIAN MEDICAL JOURNAL
    
    M. Rosandic, "Antibiotic-resistance patterns of Helicobacter pylori in Croatia: Cohort study", CROAT MED J, 42(1), 2001, pp. 45-48
97. Johnsen, SP; Sorensen, HT; Mellemkjoer, L; Blot, WJ; Nielsen, GL; McLaughlin, JK; Olsen, JH
    Hospitalisation for upper gastrointestinal bleeding associated with use oforal anticoagulants
    THROMBOSIS AND HAEMOSTASIS
    
    S.P. Johnsen et al., "Hospitalisation for upper gastrointestinal bleeding associated with use oforal anticoagulants", THROMB HAEM, 86(2), 2001, pp. 563-568
98. Roma, E; Kafritsa, Y; Panayiotou, J; Liakou, R; Constantopoulos, A
    Is peptic ulcer a common cause of upper gastrointestinal symptoms?
    EUROPEAN JOURNAL OF PEDIATRICS
    
    E. Roma et al., "Is peptic ulcer a common cause of upper gastrointestinal symptoms?", EUR J PED, 160(8), 2001, pp. 497-500
99. Buchanan, WW; Kean, WF
    Evidence based medicine: The median is not the message
    JOURNAL OF RHEUMATOLOGY
    
    W.W. Buchanan e W.F. Kean, "Evidence based medicine: The median is not the message", J RHEUMATOL, 28(11), 2001, pp. 2371-2372
100. Rodriguez, LAG; Hernandez-Diaz, S; de Abajo, FJ
     Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies
     BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
     
     L.A.G. Rodriguez et al., "Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies", BR J CL PH, 52(5), 2001, pp. 563-571